个人简历
徐鋆耀，博士，毕业于华中科技大学同济医学院，现为中山大学孙逸仙纪念医院肝胆外科硕士生导师，副教授、副主任医师。
研究领域
主要从事肝胆肿瘤的转化医学与临床研究。
近期论文
1） Zhimin Yu, Qing, Sun, Jie Wang,* Junyao Xu*. Isolated brain metastases prior to locoregional recurrence in hilar cholangiocarcinoma. Molecular and Clinical Oncology. Accepted 2）Zhimin Yu #, Jie Zhu #, Hai Jiang, Chuanchao He, Zhiyu Xiao, Jie Wang * AND Junyao Xu * . Surgical Resection and Prognostic Analysis of 142 Cases of Hilar Cholangiocarcinoma. Indian Journal of Surgery. Accepted 3）Zhimin Yu#, Qing Su,#, Yue Zhu, Jie Wan, * AND Junyao Xu* . Combined Vascular Resection and Reconstruction for Advanced Hilar Cholangiocarcinoma. International Journal of Clinical and Experimental Medicine. Accepted. 4） Dhani NC, Serra S, Pintilie M, Schwock J, Xu J, Gallinger S, Hill RP, Hedley DW*. Analysis of the intra- and intertumoral heterogeneity of hypoxia in pancreatic cancer patients receiving the nitroimidazole tracer pimonidazole. Br J Cancer. 2015 Sep 15;113(6):864-71. 5） Jin S, Wang K, Xu K, Xu J, Sun J, Chu Z, Lin D, Koeffler PH, Wang J*, Yin D. Oncogenic function and prognostic significance of protein tyrosine phosphatase PRL-1 in hepatocellular carcinoma. Oncotarget. 2014 Jun 15;5(11):3685-96. 6） Zhang Y, Zhang J, Xu K, Xiao Z, Sun J, Xu J, Wang J*, Tang Q*. PTEN/PI3K/mTOR/B7-H1 signaling pathway regulates cell progression and immuno-resistance in pancreatic cancer. Hepatogastroenterology. 2013 Oct;60(127):1766-72. 7） Xu J, Knox JJ, Ibrahimov E, Chen E, Serra S, Tsao M, Cao P, Vines D, Green DE, Metran-Nascente C, McNamara MG, Hedley DW*. Sequence dependence of MEK inhibitor AZD6244 combined with gemcitabine for the treatment of biliary cancer. Clin Cancer Res. 2013 Jan 1;19(1):118-27. 8）He C#, Xu J#, Zhang J, Xie D, Ye H, Xiao Z, Cai M, Xu K, Zeng Y, Li H, Wang J*. High expression of trimethylated histone H3 lysine 4 is associated with poor prognosis in hepatocellular carcinoma. Hum Pathol. 2012 Sep;43(9):1425-35. 9） Wu G, Yu F, Xiao Z, Xu K, Xu J, Tang W, Wang J*, Song E*. Hepatitis B virus X protein downregulates expression of the miR-16 family in malignant hepatocytes in vitro. Br J Cancer. 2011 Jun 28;105(1):146-53. 10) Chen LB#, Xu JY#, Yang Z, Wang GB*. Silencing SMYD3 in hepatoma demethylates RIZI promoter induces apoptosis and inhibits cell proliferation and migration. World J Gastroenterol. 2007 Nov 21;13(43):5718-24.
